THURSDAY, Dec. 21, 2023 (HealthDay News) — Kids who’ve survived cancer face many health challenges, and a heightened risk for diabetes is one of them, new research shows. A team at St. Jude’s Children’s Hospital in Memphis, Tenn., reports that these children have twice the odds of developing prediabetes (aContinue Reading

THURSDAY, Dec. 7, 2023 (HealthDay News) — A drug long used to curb rheumatoid arthritis may be a potent foe against another immune disorder, type 1 diabetes. Australian researchers report that baricitinib (Olumiant) appears to help patients newly diagnosed with type 1 diabetes maintain their natural ability to produce insulin,Continue Reading